These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 28506950)
1. Fertility sparing approach as the standard of care in young patients with immature teratomas. Iavazzo C; Vorgias G; Iavazzo PE; Gkegkes ID J Turk Ger Gynecol Assoc; 2017 Mar; 18(1):43-47. PubMed ID: 28506950 [TBL] [Abstract][Full Text] [Related]
2. Outcome of patients with stage I immature teratoma after surveillance or adjuvant chemotherapy. Marino G; Grassi T; De Ponti E; Negri S; Testa F; Giuliani D; Delle Marchette M; Dell'Oro C; Fumagalli D; Donatiello G; Besana G; Marchetta L; Bonazzi CM; Lissoni AA; Landoni F; Fruscio R Front Oncol; 2024; 14():1330481. PubMed ID: 38371620 [TBL] [Abstract][Full Text] [Related]
3. Pure Immature Teratoma of the Ovary in Adults: Thirty-Year Experience of a Single Tertiary Care Center. Alwazzan AB; Popowich S; Dean E; Robinson C; Lotocki R; Altman AD Int J Gynecol Cancer; 2015 Nov; 25(9):1616-22. PubMed ID: 26332392 [TBL] [Abstract][Full Text] [Related]
4. Current Strategy for the Treatment of Ovarian Germ Cell Tumors: Role of Extensive Surgery. Li J; Wu X Curr Treat Options Oncol; 2016 Aug; 17(8):44. PubMed ID: 27357180 [TBL] [Abstract][Full Text] [Related]
5. The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors. Fang C; Zhao L; Chen X; Yu A; Xia L; Zhang P BMC Cancer; 2018 Nov; 18(1):1147. PubMed ID: 30463533 [TBL] [Abstract][Full Text] [Related]
6. Fertility-sparing surgery for patients with malignant ovarian germ cell tumors: 10 years of clinical experience from a tertiary referral center. Mikuš M; Benco N; Matak L; Planinić P; Ćorić M; Lovrić H; Radošević V; Puževski T; Bajt M; Vujić G Arch Gynecol Obstet; 2020 May; 301(5):1227-1233. PubMed ID: 32253553 [TBL] [Abstract][Full Text] [Related]
7. Characteristics, treatment and outcomes of women with immature ovarian teratoma, 1998-2012. Jorge S; Jones NL; Chen L; Hou JY; Tergas AI; Burke WM; Ananth CV; Neugut AI; Herhshman DL; Wright JD Gynecol Oncol; 2016 Aug; 142(2):261-6. PubMed ID: 27222024 [TBL] [Abstract][Full Text] [Related]
8. Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors. Park JY; Kim DY; Suh DS; Kim JH; Kim YM; Kim YT; Nam JH Gynecol Oncol; 2017 Jun; 145(3):513-518. PubMed ID: 28372870 [TBL] [Abstract][Full Text] [Related]
9. Successful infertility treatment following fertility-sparing surgery and chemotherapy for ovarian immature teratoma: a case report and a literature review. Matsushita H; Tani H Reprod Med Biol; 2011 Sep; 10(3):193-198. PubMed ID: 29699094 [TBL] [Abstract][Full Text] [Related]
11. Immature Teratoma: A Case Report of a Monster Tumor in the Pediatric Age Group. Patel D; Tayade S; Sharma S; Reddy LS Cureus; 2023 Nov; 15(11):e48989. PubMed ID: 38111418 [TBL] [Abstract][Full Text] [Related]
12. Ovarian immature teratoma: treatment and outcome in a single institutional cohort. Vicus D; Beiner ME; Clarke B; Klachook S; Le LW; Laframboise S; Mackay H Gynecol Oncol; 2011 Oct; 123(1):50-3. PubMed ID: 21764111 [TBL] [Abstract][Full Text] [Related]
13. Early stage ovarian immature teratoma, surveillance or chemotherapy after surgery? A propensity score matched analysis. Zhang X; Yang J; Wang J; Zhang Y; Yang J Gynecol Oncol Rep; 2022 Apr; 40():100976. PubMed ID: 35434235 [TBL] [Abstract][Full Text] [Related]
14. Survival and reproductive function after treatment of malignant germ cell ovarian tumors. Zanetta G; Bonazzi C; Cantù M; Binidagger S; Locatelli A; Bratina G; Mangioni C J Clin Oncol; 2001 Feb; 19(4):1015-20. PubMed ID: 11181664 [TBL] [Abstract][Full Text] [Related]
15. Long-term survival after fertility-sparing surgery for epithelial ovarian cancer. Schlaerth AC; Chi DS; Poynor EA; Barakat RR; Brown CL Int J Gynecol Cancer; 2009 Oct; 19(7):1199-204. PubMed ID: 19823055 [TBL] [Abstract][Full Text] [Related]
16. Clinical management of malignant ovarian germ cell tumors: A 26-year experience in a tertiary care institution. Hu T; Fang Y; Sun Q; Zhao H; Ma D; Zhu T; Wang C Surg Oncol; 2019 Dec; 31():8-13. PubMed ID: 31446304 [TBL] [Abstract][Full Text] [Related]
17. Mature and immature teratoma: A report from the second Italian pediatric study. Terenziani M; D'Angelo P; Inserra A; Boldrini R; Bisogno G; Babbo GL; Conte M; Dall' Igna P; De Pasquale MD; Indolfi P; Piva L; Riccipetitoni G; Siracusa F; Spreafico F; Tamaro P; Cecchetto G Pediatr Blood Cancer; 2015 Jul; 62(7):1202-8. PubMed ID: 25631333 [TBL] [Abstract][Full Text] [Related]
18. A retrospective study of reproductive outcomes after fertility-sparing surgery and postoperative adjuvant chemotherapy in malignant ovarian germ cell tumors and sex cord-stromal tumors. Zhang N; Chen R; Hua K; Zhang Y J Ovarian Res; 2017 Jul; 10(1):52. PubMed ID: 28750644 [TBL] [Abstract][Full Text] [Related]
19. Is adjuvant chemotherapy indicated in stage I pure immature ovarian teratoma (IT)? A multicentre Italian trial in ovarian cancer (MITO-9). Mangili G; Scarfone G; Gadducci A; Sigismondi C; Ferrandina G; Scibilia G; Viganò R; Tateo S; Villa A; Lorusso D Gynecol Oncol; 2010 Oct; 119(1):48-52. PubMed ID: 20599258 [TBL] [Abstract][Full Text] [Related]